![Kaouthar Lbiati](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 45 357 $ al 30/06/2026
Kaouthar Lbiati is currently an Independent Director at Theralase Technologies, Inc. since 2023 and Vice President-Strategy & Corporate Development at Cytovia Therapeutics, Inc. Former positions include Chief Executive, Financial Officer & Director at Hepion Pharmaceuticals, Inc. from 2025 to 2026, Executive Director-Strategic Planning at Immune Pharmaceuticals, Inc., and Head-Strategy & Portfolio at Steba Biotech SA. Education includes graduate degrees from London School of Economics & Political Science and ESSEC Business School, and a doctorate from Mohammed V University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/05/2026 | 246.507 ( 0,08 % ) | 45 357 $ | 30/06/2026 | |
| 28/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Director/Miembro de la Junta | 06/06/2023 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director Ejecutivo | 16/03/2026 |
| IMMUNE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Steba Biotech SA
 Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Theralase Technologies, Inc.
 Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mohammed V University
 Mohammed V University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Steba Biotech SA
Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Commercial Services |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
